Point-of-Care Cerebrospinal Fluid Detection

Area of Science:

• Biomedical Engineering
• Otolaryngology
• Clinical Diagnostics

Background:

• Cerebrospinal fluid (CSF) leaks are serious otolaryngology complications, often resulting from skull base injuries.
• Distinguishing CSF from other secretions can be challenging in clinical settings.
• Current laboratory assays for CSF detection are time-consuming.

Purpose of the Study:

• To develop a rapid, user-friendly, point-of-care device for detecting cerebrospinal fluid leaks.
• To address the limitations of existing labor-intensive and slow laboratory diagnostic methods.

Main Methods:

• Development of a barcode-style lateral-flow immunoassay.
• Utilized antibodies specific for beta-trace protein (BTP), a CSF-specific biomarker.
• Validated the device using known BTP concentrations and clinical samples.

Main Results:

• The novel device can semiquantitatively detect BTP concentrations ranging from 0.3-90 mg/L.
• This detection range is sufficient for diagnosing CSF leaks.
• Beta-trace protein is confirmed as an excellent target for rapid clinical detection.

Conclusions:

• The first point-of-care (POC) device for CSF leak detection has been created and validated.
• This device offers a feasible, efficient, and cost-effective method for identifying CSF leaks.
• The POC device has the potential to minimize costs and improve patient outcomes.